Literature DB >> 9286054

Generation of bovine immune colostrum against Streptococcus mutans and Streptococcus sobrinus and its effect on glucose uptake and extracellular polysaccharide formation by mutans streptococci.

V Loimaranta1, J Tenovuo, S Virtanen, P Marnila, E L Syväoja, T Tupasela, H Korhonen.   

Abstract

Due to potential side-effects of active immunization by cariogenic mutans streptococci, oral administration of passively-derived antibodies could be a more acceptable way to reduce colonization and virulence of these microorganisms in human dentition. The aim of this study was to produce antistreptococcal immunoglobulins into bovine colostrum and explore the possible antibacterial mechanisms of these immunoglobulins against mutans streptococci. Specific serum IgG antibodies to whole cell antigens of both Streptococcus mutans and Streptococcus sobrinus increased rapidly in cows during immunization and were high also in the final whey-product. Low concentration (0.5% w/v) of bovine immune preparation inhibited significantly the incorporation of [14C]glucose by both S. mutans and S. sobrinus. Higher concentration (> 1%) was needed to inhibit the glucosyltransferase or fructosyltransferase activities of these bacteria. No such inhibitory effects were observed with the control preparation from the non-immunized cows. Our results indicate that bovine immune colostrum has a significant inhibitory potential against mutans streptococci, apparently dependent on the presence of specific IgG antibodies against S. mutans and S. sobrinus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286054     DOI: 10.1016/s0264-410x(97)00027-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Passive immunization with milk produced from an immunized cow prevents oral recolonization by Streptococcus mutans.

Authors:  Y Shimazaki; M Mitoma; T Oho; Y Nakano; Y Yamashita; K Okano; Y Nakano; M Fukuyama; N Fujihara; Y Nada; T Koga
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells.

Authors:  T Adar; A Ben Ya'acov; G Lalazar; Y Lichtenstein; D Nahman; M Mizrahi; V Wong; B Muller; G Rawlin; Y Ilan
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

4.  Passive immunization with bovine milk containing antibodies to a cell surface protein antigen-glucosyltransferase fusion protein protects rats against dental caries.

Authors:  Morihide Mitoma; Takahiko Oho; Naoko Michibata; Kaoru Okano; Yutaka Nakano; Masataka Fukuyama; Toshihiko Koga
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH.

Authors:  Meir Mizrahi; Yehudit Shabat; Ami Ben Ya'acov; Gadi Lalazar; Tomer Adar; Victor Wong; Brian Muller; Grant Rawlin; Yaron Ilan
Journal:  J Inflamm Res       Date:  2012-12-20

Review 6.  Perspectives on immunoglobulins in colostrum and milk.

Authors:  Walter L Hurley; Peter K Theil
Journal:  Nutrients       Date:  2011-04-14       Impact factor: 5.717

7.  Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody.

Authors:  Christopher R Doyle; Liise-anne Pirofski
Journal:  MBio       Date:  2016-02-02       Impact factor: 7.867

Review 8.  Milk immunoglobulins for health promotion.

Authors:  Raj Mehra; Pertti Marnila; Hannu Korhonen
Journal:  Int Dairy J       Date:  2006-08-21       Impact factor: 3.032

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.